Stereotaxis (STXS) Current Deferred Revenue (2010 - 2026)

Stereotaxis (STXS) has reported Current Deferred Revenue for 17 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 28.36% year-over-year to $7.1 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 28.36% decrease from a year earlier, with the FY2025 full-year figure at $6.2 million, down 29.75% from the prior year.
• Current Deferred Revenue was $7.1 million for Q1 2026 at Stereotaxis, up from $6.2 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $9.9 million in Q2 2023 and troughed at $6.2 million in Q4 2025.
• A 5-year average of $8.2 million and a median of $8.3 million in 2023 frame the typical range for Current Deferred Revenue.
• The widest YoY moves for Current Deferred Revenue: up 31.15% in 2025, down 29.75% in 2025.
• Over 5 years, Current Deferred Revenue stood at $9.0 million in 2022, then dropped by 7.8% to $8.3 million in 2023, then gained by 6.92% to $8.9 million in 2024, then declined by 29.75% to $6.2 million in 2025, then rose by 13.39% to $7.1 million in 2026.
• The last three Current Deferred Revenue figures came in at $7.1 million (Q1 2026), $6.2 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.